Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reversal of symptomatic hyperprolactinemia by aripiprazole.

× No keyword cloud information.

11 in total

Review 1. Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

Authors: Gabriele Masi; Francesca Liboni
Journal: Drugs Date: 2011-01-22 Impact factor: 9.546

2. Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy.

Authors: Rebecca L Curran; Ismail A Badran; Virginia Peppers; Ernest V Pedapati; Christoph U Correll; Melissa P DelBello
Journal: J Child Adolesc Psychopharmacol Date: 2016-04-27 Impact factor: 2.576

Review 3. Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors: Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal: CNS Drugs Date: 2009-12 Impact factor: 5.749

4. Aripiprazole for olanzapine-induced symptomatic hyper prolactinemia.

Authors: Ashish Aggarwal; Manish Jain; Amit Garg; R C Jiloha
Journal: Indian J Pharmacol Date: 2010-02 Impact factor: 1.200

5. Focus on aripiprazole: a review of its use in child and adolescent psychiatry.

Authors: Masa'il Greenaway; Dean Elbe
Journal: J Can Acad Child Adolesc Psychiatry Date: 2009-08

Review 6. Emerging role of aripiprazole for treatment of irritability associated with autistic disorder in children and adolescents.

Authors: Joan Stachnik; Michael Gabay
Journal: Adolesc Health Med Ther Date: 2010-09-15

Review 7. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Authors: J Peuskens; L Pani; J Detraux; M De Hert
Journal: CNS Drugs Date: 2014-05 Impact factor: 5.749

8. The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study.

Authors: Kojiro Hashimoto; Norio Sugawara; Masamichi Ishioka; Kazuhiko Nakamura; Norio Yasui-Furukori
Journal: Neuropsychiatr Dis Treat Date: 2014-08-22 Impact factor: 2.570

Review 9. Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials.

Authors: Meiling Meng; Wei Li; Shaowei Zhang; Hongyan Wang; Jianhua Sheng; Jijun Wang; Chunbo Li
Journal: Shanghai Arch Psychiatry Date: 2015-02-25

10. Pharmacological causes of hyperprolactinemia.

Authors: Daria La Torre; Alberto Falorni
Journal: Ther Clin Risk Manag Date: 2007-10 Impact factor: 2.423